MP
CELU icon

Mangrove Partners’s Celularity CELU Stock Holding History

Mangrove Partners’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-70,000
Closed -$6.96M – 76
2019
Q3 		$6.96M Buy
+70,000
New +$6.87M 0.84% 30

Other funds holding CELU

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
RIA
RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Mangrove Partners's CELU Position: Q4 2019 in Review

Mangrove Partners sold out of Celularity (CELU) in Q4 2019, closing a stake of 70,000 shares — an estimated $6.96M sold.

Mangrove Partners first reported a position in CELU in Q3 2019 and held it in 1 quarter. The position peaked at $6.96M in Q3 2019. 29 funds tracked by Wall St. Rank hold CELU as of Q4 2019.

  • Mangrove Partners reported no remaining Celularity position as of Q4 2019 after selling out during the quarter.
  • Mangrove Partners sold 70,000 Celularity shares in Q4 2019, an estimated $6.96M.
  • Mangrove Partners first reported a position in Celularity in Q3 2019 and held it in 1 quarter.
  • Mangrove Partners's Celularity position peaked at $6.96M in Q3 2019.
  • 29 funds tracked by Wall St. Rank held Celularity as of Q4 2019.

Based on Mangrove Partners's 13F filing for Q4 2019, filed 14 Feb 2020.